Posts

Psychedelic Business Spotlight – June 10

,
This week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed's stock is removed from an index; and...

Psychedelic Business Spotlight – April 15

,
This week in psychedelic business news: The industry's first major merger; NeonMind launches clinics; a portfolio of patents is acquired.
Numinus Acquiring Novamind in First Major Psychedelics MergerShutterstock

Numinus Acquiring Novamind in First Major Psychedelics Merger

,
This deal will make Numinus the psychedelic medicines company with the highest revenue, though of course there is still a long road to profitability.

Psychedelic Business Spotlight: November 19

,
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
Psychedelic Business Spotlight: October 8, 2021

Psychedelic Business Spotlight: October 8, 2021

,
This week in psychedelic business news: Enveric Biosciences uses AI to identify viable psychedelic drug candidates; Novamind launches end-of-life palliative care program; and PharmaTher tests ketamine to treat...
Psychedelic Business Spotlight: September 17, 2021

Psychedelic Business Spotlight: September 17, 2021

,
This week in psychedelic business news: Wesana teams up with MAPS, MindBio Therapeutics announces world-class research and drug development facility, and Awakn Life Sciences buys up ketamine clinics across...
Psychedelic Spotlight Business Round Up July 30

Psychedelic Business Spotlight: July 30, 2021

,
This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.